期刊文献+

幽门螺杆菌共识修改背景和概况 被引量:6

Backgrounds and outlines of updated consensus on helicobacter pylori
原文传递
导出
摘要 第四届全国幽门螺杆菌(Hp)共识会议于2012年4月26—28日在江西井冈山召开,与会专家对专题报告和共识意见内容开展了热烈讨论,对一些问题进行了协商,最后达成了共识。本共识以2007年庐山共识报告为基础,参考国际上最新的亚太地区、世界胃肠病组织、马斯特里赫特(MaatrichtⅣ)共识报告,并结合中国Hp感染国情修订而成。共识由Hp根除治疗适应证、感染的检测和根除治疗3部分组成。本文将就共识的修改背景和概括作一介绍。 Held in Jing-gang Mountain ,Jiangxi province, between April 26th and 28th 2012, the Forth National Helicobacter pylori (ft. pylori) Consensus Conference has led experts to discuss extensively on the specialist reports and consensus recommendations. This has contributed to the final version following expert consultancy on key issues. Based on the Lushan Consensus issued in 2007 and by incorporating the conditions of H. pylori infection in Chinese population, the current con- sensus was established by referring to the latest consensus reports of Asia-Pacific Region, World Gastroenteropathy Organization and Maatrieht IV. The consensus consisted of 3 domains, namely, indications for H. pylori eradication, diagnosis of infection and regimens for eradication. Here, the backgrounds and sketches for the latest updates were outlined.
作者 谢川 吕农华
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2013年第3期176-178,共3页 Chinese Journal of Practical Internal Medicine
关键词 幽门螺杆菌 非类固醇类抗炎药 质子泵抑制剂 helicobacter pylori nonsteroidal anti-inflammatory drugs proton pump inhibitor
  • 相关文献

参考文献3

二级参考文献17

共引文献577

同被引文献83

  • 1Qin-Juan Sun, Xiao Liang, Qing Zheng, Wei-Qi Gu, WenZhong Liu, Shu-Dong Xiao, Hong Lu.Resistance of Helicobacter pylori to antibiotics from 2000 to 2009 in Shanghai[J].World Journal of Gastroenterology,2010,16(40):5118-5121. 被引量:91
  • 2李玉洁,杨庆,朱晓新.球囊导管损伤法复制兔动脉粥样硬化模型炎性反应的特征[J].中华老年心脑血管病杂志,2007,9(4):283-284. 被引量:4
  • 3郑芝田.胃肠病学[M].北京:人民卫生出版社,1993.606.
  • 4Molina-Infante J, Gisbert JP. Update on the efficacy of triple therapy for Helicobacter pyloriinfection and clarithromycin resistance rates in Spain(2007-2012 ) [ J]. Gastroenteroi Hepatol, 2013,36(6) :375-381.
  • 5Ameriso SF,fridman EA,Leiguarda RC,et al.Detection of Helelicobacter pylori in human carotid at herosclerotic plaques[J].Stroke,2001,32(1):385-391.
  • 6Mendall MA,Groggin PM,Molineaux N,et al.Relation of Helicobacterpylori and coronary heart disease[J].Br Heart J,1994,7(1):437.
  • 7Diomedi M,Pietroiusti A,Silvestrini M,et al.Cag Apositve Helicobacrer pylori strain influence the natural history of atherosclerotic stroke[J].Neurology,2004,63(3):800-804.
  • 8Stone AF,Mendall MA,Kaski JC,et al.Effect of treatment for Chlamydia pneumoniae and Helieobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes:South Thames trial of antibiotics in myoeardial infarction and unstable angina(STAMINA)[J].Circulation,2002,10(6):1219-1223.
  • 9施新猷.人与动物计量折算系数表[J].现代医学实验动物学,2005,6(14):333-335.
  • 10Milio G,Conado E,Sorrentino D,et al.Asymptomatic Carotid Lesions and Aging:Role of Hypertension and OthelTraditional and EmergingRisk Factors[J].Arch Med Res,2006,37(3):342-347.

引证文献6

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部